A J Morales

No ORCID on file · 10 papers in corpus · active 1994-1999

Study types

  • article 5
  • other 3
  • case-report 1
  • review 1

Condition tags

  • mesh:D004715 10
  • endometriosis 9
  • mesh:D017699 2
  • infertility 1
other 1999
Autoantibodies to markers of oxidative stress are elevated in women with endometriosis
Fertility and Sterility ·doi:10.1016/s0015-0282(99)00145-4

OBJECTIVE: To measure autoantibodies that recognize oxidatively modified proteins in the sera of women with surgically proven endometriosis. DESIGN: Prospective study. SETTING: Tertiary care academic medical center. PATIENT(S): Women und…

other 1999
Endoscopic treatment for endometriosis
Obstetrics and gynecology clinics of North America ·doi:10.1016/s0889-8545(05)70062-0

Endometriosis is best regarded as a chronic disease that can vary in symptomatology over time. Endoscopic therapy for relief of pelvic pain as well as infertility is a therapeutic option. The formation of a rational treatment plan before su…

article 1998
Evidence for Oxidatively Modified Lipid-Protein Complexes in Endometrium and Endometriosis
Fertility and Sterility ·doi:10.1016/s0015-0282(98)00087-9
article 1998
Lysophosphatidyl Choline, a Chemotactic Factor for Monocytes/T-Lymphocytes Is Elevated in Endometriosis
The Journal of clinical endocrinology and metabolism ·doi:10.1210/jcem.83.6.4823

Inflammatory processes have been hypothesized to mediate some of the clinical sequelae associated with endometriosis. The peritoneal fluid (PF) of women with endometriosis is known to contain more inflammatory cells and their associated cyt…

article 1998
Macrophage Scavenger Receptor(s) and Oxidatively Modified Proteins in Endometriosis
Fertility and Sterility ·doi:10.1016/s0015-0282(98)00088-0
case-report 1998
Preliminary report on the treatment of endometriosis with low-dose mifepristone (RU 486)
American Journal of Obstetrics and Gynecology ·doi:10.1016/s0002-9378(98)70316-3

OBJECTIVE: We have previously shown that treatment with mifepristone, 50 to 100 mg daily, results in amenorrhea, anovulation, and symptomatic improvement in women with endometriosis. In this study we lowered the dose to 5 mg daily to determ…

review 1996
Mifepristone: Clinical Application in General Gynecology
Clinical obstetrics and gynecology ·doi:10.1097/00003081-199606000-00018

RU-486, the first clinically available antiprogestin, has numerous gynecologic applications beyond first-trimester pregnancy termination. Long-term administration of 2 mg/day of RU-486 suppresses ovulation while maintaining serum estrogen l…

other 1996
Treatment of endometriosis with the antiprogesterone mifepristone (RU486)
Fertility and Sterility ·doi:10.1016/s0015-0282(16)58022-4

OBJECTIVE: To evaluate the safety and efficacy of an antiprogesterone (mifepristone, RU486; Roussel-Uclaf, Romaineville, France) on endometriosis. DESIGN: An open, prospective clinical trial. SETTING: The clinical practice of an academic …

article 1995
Endometrial effects of long-term low-dose administration of RU486
Fertility and Sterility ·doi:10.1016/s0015-0282(16)57478-0
article 1994
Clinical efficacy of the antiprogesterone RU486 in the treatment of endometriosis and uterine fibroids
Human Reproduction ·doi:10.1093/humrep/9.suppl_1.116

To evaluate the long-term effects of treatment with RU486 and to test its efficacy in endometriosis, a 3-month trial was conducted to evaluate the effects of daily administration (100 mg/day or approximately 2 mg/kg/day) on the functional a…